Inicio>>Signaling Pathways>> Others>>Fumarate hydratase-IN-2 sodium salt

Fumarate hydratase-IN-2 sodium salt

Catalog No.GC34383

La sal sÓdica de fumarato hidratasa-IN-2 (compuesto 3) es un inhibidor competitivo y permeable a las células de la fumarato hidratasa (Ki = 4,5 μM) con citotoxicidad dependiente de nutrientes.

Products are for research use only. Not for human use. We do not sell to patients.

Fumarate hydratase-IN-2 sodium salt Chemical Structure

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
312,00 $
Disponible
1mg
138,00 $
Disponible
5mg
321,00 $
Disponible
10mg
459,00 $
Disponible
25mg
920,00 $
Disponible
50mg
1.471,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

.Fumarate hydratase is an enzyme of the TCA cycle and cell-permeable inhibitors (1) inhibition of fumarate hydratase can contribute to tumorigenicity in some cells. (2) The use of a photoaffinity labeling strategy identified fumarate hydratase as the principal pharmacological target. Final biochemical studies confirmed dose-dependent, competitive inhibition of this enzyme (3) Chemical inhibition of fumarate hydratase renders cells highly dependent on glucose metabolism for survival.

[1]. Takeuchi T et al. Identification of fumarate hydratase inhibitors with nutrient-dependent cytotoxicity. J Am Chem Soc. 2015 Jan 21;137(2):564-7.

Reseñas

Review for Fumarate hydratase-IN-2 sodium salt

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fumarate hydratase-IN-2 sodium salt

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.